Assurance Healthcare Limited: FY2025 Financial Performance Review
Assurance Healthcare Limited, a Singapore-listed provider of healthcare support and managed care solutions, released its interim financial statements for the six months and full year ended 31 December 2025. Below is a comprehensive analysis of the company’s financial performance, key metrics, and outlook for investors.
Key Financial Metrics and Comparative Analysis
| Metric |
2H 2025 |
1H 2025 |
2H 2024 |
YoY Change (2H) |
QoQ Change |
| Revenue |
S\$453,000 |
S\$287,000 |
S\$283,000 |
+60% |
+58% |
| Operating Loss After Tax |
S\$295,000 |
S\$487,000 |
S\$845,000 |
-65% |
-39% |
| EPS (Basic & Diluted) |
-0.11¢ |
-0.17¢ |
-0.25¢ |
+56% |
+35% |
| Dividend |
None |
None |
None |
No change |
No change |
| Metric |
FY2025 |
FY2024 |
YoY Change |
| Revenue |
S\$740,000 |
S\$588,000 |
+26% |
| Net Loss |
S\$782,000 |
S\$1,344,000 |
-42% |
| EPS (Basic & Diluted) |
-0.28¢ |
-0.43¢ |
+35% |
| Dividend |
None |
None |
No change |
Historical Performance Trends
- Revenue Growth: Revenue increased by 26% YoY, supported by higher service volumes from both existing and newly onboarded clients.
- Improved Losses: Net loss narrowed by 42% YoY, reflecting both revenue growth and cost containment efforts.
- Cash Flow: Net cash used in operating activities was S\$538,000 in FY2025, an improvement from S\$1,055,000 outflow in FY2024. Cash and cash equivalents declined from S\$2,165,000 to S\$1,237,000, primarily due to operating losses and investment in software systems.
- Asset Development: Non-current assets increased due to capitalisation of operating software under development, suggesting ongoing investment in digital capabilities.
Exceptional Items and Expenses
- Expected Credit Losses: FY2025 saw a reversal of S\$40,000 in ECL on trade receivables, compared to a S\$215,000 allowance in FY2024. This reflects improved collection rates following stricter credit policies.
- Professional Fees: Other operating expenses decreased by S\$121,000 YoY, mainly due to lower professional fees and the reversal of government grants recognised in FY2024.
- No Dividends: No dividends were declared for FY2025 or FY2024, due to ongoing losses.
Review of Financial Position
- Net Asset Value: NAV per share decreased from 2.66¢ to 2.39¢ (group) and from 2.78¢ to 2.53¢ (company), reflecting the losses incurred.
- Liabilities: Current liabilities increased, mainly due to higher trade and other payables in line with service volume growth. Non-current liabilities decreased as bank borrowings were repaid.
- Share Capital and Structure: No changes in share capital, treasury shares, or convertibles during the period. All issued shares are fully paid.
Related Party Transactions and Mandates
- No significant related party transactions occurred during the period.
- No shareholder mandate for interested person transactions is in place.
Industry Trends and Outlook
The Group operates in Singapore’s resilient healthcare services sector, focusing on Third-Party Administrator (TPA) services, underpinned by statutory healthcare requirements and demand for employee coverage. Competitive intensity remains high, with employers and insurers emphasizing cost containment and efficiency. Regulatory compliance and data security continue to drive system investments and operating costs.
Management highlights continued focus on operational efficiency, compliance, and digital system enhancements to support ongoing operations.
Chairman’s Statement
“The Group continues to monitor industry and regulatory developments and remains focused on operational efficiency, regulatory compliance, system enhancements, and service quality to support its ongoing operations.”
The tone is neutral, emphasizing prudent management and operational improvements without making aggressive growth claims.
Conclusion & Investor Recommendations
Overall Performance: Assurance Healthcare Limited demonstrated substantial operational improvement in FY2025, with revenue growth and a significant reduction in net loss. However, the company continues to report losses, with no dividend payout and a declining net asset value. Cash reserves have decreased, but the group is investing in software and digital capabilities to enhance efficiency and service quality.
Recommendation for Current Shareholders: If you are currently holding this stock, consider maintaining your position if you believe in the company’s strategy to achieve profitability through client growth, cost management, and digital transformation. However, monitor cash flows and regulatory risks closely, as sustained losses may impact long-term value.
Recommendation for Potential Investors: If you are not holding this stock, it may be prudent to wait for evidence of sustained profitability or clearer positive cash flow trends before initiating a position. The company is improving operational performance, but ongoing losses and lack of dividend may not suit risk-averse investors.
Disclaimer: This analysis is based solely on the company’s published financial statements and does not constitute investment advice. Investors should conduct their own due diligence and consult professional advisors before making any investment decisions.
View Assurance HC Historical chart here
